Advertisement
Screener

SANUWAVE Health, Inc. (SNWV) Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)

2.8 / 5 stars · 36/65 Roast Me

SANUWAVE Health, Inc. Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)

SANUWAVE Health, Inc. (SNWV) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $183.13 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-14.

Discontinued › Notes › and Others

us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2020-08-14

  • SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2020-06-30 was $99.82K, a 194.52% increase year-over-year.
  • SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2020-03-31 was $83.31K.
  • SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2019-09-30 was -$44.08K, a 483.43% decline year-over-year.
  • SANUWAVE Health, Inc. accounts receivable, allowance for credit loss, period increase (decrease) for the quarter ending 2019-06-30 was $33.89K.
Period endAccounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 3 monthAccounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 monthAccounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 9 month
2020-06-30$99.82K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$183.13K
10-Q · filed 2020-08-14
2020-03-31$83.31K
10-Q · filed 2020-05-15
2019-09-30-$44.08K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$10.19K
derived: sum of 2 quarters · filed 2020-08-14
-$18.84K
10-Q · filed 2019-11-14
2019-06-30$33.89K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$25.25K
10-Q · filed 2020-08-14
2019-03-31-$8.64K
10-Q · filed 2020-05-15
2018-09-30$11.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
-$30.23K
derived: sum of 2 quarters · filed 2019-11-14
-$49.85K
10-Q · filed 2019-11-14
2018-06-30-$41.73K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
-$61.34K
10-Q · filed 2019-08-14
2018-03-31-$19.61K
10-Q · filed 2019-05-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEPHROS INC (NEPH)United States$0.046B23.02
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
Spectral AI, Inc. (MDAI)United States$0.052B
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
TELA Bio, Inc. (TELA)United States$0.057B-0.82
HeartBeam, Inc. (BEAT)United States$0.022B-2.08